Global and United States Pharmaceutical Asset Managements Market Report & Forecast 2023-2028

Report ID: 1845167 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pharmaceutical Asset Managements Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Pharmaceutical Asset Managements Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Pharmaceutical Asset Managements Market Size for the Year 2017-2028
        1.2.2 Global Pharmaceutical Asset Managements Market Size for the Year 2017-2028
    1.3 Pharmaceutical Asset Managements Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Pharmaceutical Asset Managements in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Pharmaceutical Asset Managements Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Pharmaceutical Asset Managements Market Dynamics
        1.4.1 Pharmaceutical Asset Managements Industry Trends
        1.4.2 Pharmaceutical Asset Managements Market Drivers
        1.4.3 Pharmaceutical Asset Managements Market Challenges
        1.4.4 Pharmaceutical Asset Managements Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Pharmaceutical Asset Managements by Type
    2.1 Pharmaceutical Asset Managements Market Segment by Type
        2.1.1 Hardware (Pharma Asset)
        2.1.2 Software (Pharma Asset)
    2.2 Global Pharmaceutical Asset Managements Market Size by Type (2017, 2022 & 2028)
    2.3 Global Pharmaceutical Asset Managements Market Size by Type (2017-2028)
    2.4 United States Pharmaceutical Asset Managements Market Size by Type (2017, 2022 & 2028)
    2.5 United States Pharmaceutical Asset Managements Market Size by Type (2017-2028)
3 Pharmaceutical Asset Managements by Application
    3.1 Pharmaceutical Asset Managements Market Segment by Application
        3.1.1 Anti-Drug Counterfeiting
        3.1.2 Supply Chain Management
        3.1.3 Other
    3.2 Global Pharmaceutical Asset Managements Market Size by Application (2017, 2022 & 2028)
    3.3 Global Pharmaceutical Asset Managements Market Size by Application (2017-2028)
    3.4 United States Pharmaceutical Asset Managements Market Size by Application (2017, 2022 & 2028)
    3.5 United States Pharmaceutical Asset Managements Market Size by Application (2017-2028)
4 Global Pharmaceutical Asset Managements Competitor Landscape by Company
    4.1 Global Pharmaceutical Asset Managements Market Size by Company
        4.1.1 Top Global Pharmaceutical Asset Managements Companies Ranked by Revenue (2021)
        4.1.2 Global Pharmaceutical Asset Managements Revenue by Player (2017-2022)
    4.2 Global Pharmaceutical Asset Managements Concentration Ratio (CR)
        4.2.1 Pharmaceutical Asset Managements Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Pharmaceutical Asset Managements in 2021
        4.2.3 Global Pharmaceutical Asset Managements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Pharmaceutical Asset Managements Headquarters, Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Pharmaceutical Asset Managements Headquarters and Area Served
        4.3.2 Global Pharmaceutical Asset Managements Companies Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Pharmaceutical Asset Managements Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Pharmaceutical Asset Managements Market Size by Company
        4.5.1 Top Pharmaceutical Asset Managements Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Pharmaceutical Asset Managements Revenue by Players (2020, 2021 & 2022)
5 Global Pharmaceutical Asset Managements Market Size by Region
    5.1 Global Pharmaceutical Asset Managements Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Pharmaceutical Asset Managements Market Size by Region (2017-2028)
        5.2.1 Global Pharmaceutical Asset Managements Market Size by Region: 2017-2022
        5.2.2 Global Pharmaceutical Asset Managements Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Pharmaceutical Asset Managements Market Size YoY Growth 2017-2028
        6.1.2 North America Pharmaceutical Asset Managements Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Pharmaceutical Asset Managements Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Pharmaceutical Asset Managements Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Pharmaceutical Asset Managements Market Size YoY Growth 2017-2028
        6.3.2 Europe Pharmaceutical Asset Managements Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Pharmaceutical Asset Managements Market Size YoY Growth 2017-2028
        6.4.2 Latin America Pharmaceutical Asset Managements Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Pharmaceutical Asset Managements Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Pharmaceutical Asset Managements Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 McKesson Corporation
        7.1.1 McKesson Corporation Company Details
        7.1.2 McKesson Corporation Business Overview
        7.1.3 McKesson Corporation Pharmaceutical Asset Managements Introduction
        7.1.4 McKesson Corporation Revenue in Pharmaceutical Asset Managements Business (2017-2022)
        7.1.5 McKesson Corporation Recent Development
    7.2 Cerner Corporation
        7.2.1 Cerner Corporation Company Details
        7.2.2 Cerner Corporation Business Overview
        7.2.3 Cerner Corporation Pharmaceutical Asset Managements Introduction
        7.2.4 Cerner Corporation Revenue in Pharmaceutical Asset Managements Business (2017-2022)
        7.2.5 Cerner Corporation Recent Development
    7.3 Siemens Healthcare
        7.3.1 Siemens Healthcare Company Details
        7.3.2 Siemens Healthcare Business Overview
        7.3.3 Siemens Healthcare Pharmaceutical Asset Managements Introduction
        7.3.4 Siemens Healthcare Revenue in Pharmaceutical Asset Managements Business (2017-2022)
        7.3.5 Siemens Healthcare Recent Development
    7.4 GE Healthcare
        7.4.1 GE Healthcare Company Details
        7.4.2 GE Healthcare Business Overview
        7.4.3 GE Healthcare Pharmaceutical Asset Managements Introduction
        7.4.4 GE Healthcare Revenue in Pharmaceutical Asset Managements Business (2017-2022)
        7.4.5 GE Healthcare Recent Development
    7.5 Allscripts
        7.5.1 Allscripts Company Details
        7.5.2 Allscripts Business Overview
        7.5.3 Allscripts Pharmaceutical Asset Managements Introduction
        7.5.4 Allscripts Revenue in Pharmaceutical Asset Managements Business (2017-2022)
        7.5.5 Allscripts Recent Development
    7.6 Epic System
        7.6.1 Epic System Company Details
        7.6.2 Epic System Business Overview
        7.6.3 Epic System Pharmaceutical Asset Managements Introduction
        7.6.4 Epic System Revenue in Pharmaceutical Asset Managements Business (2017-2022)
        7.6.5 Epic System Recent Development
    7.7 IBM Corporation
        7.7.1 IBM Corporation Company Details
        7.7.2 IBM Corporation Business Overview
        7.7.3 IBM Corporation Pharmaceutical Asset Managements Introduction
        7.7.4 IBM Corporation Revenue in Pharmaceutical Asset Managements Business (2017-2022)
        7.7.5 IBM Corporation Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Pharmaceutical Asset Managements Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Pharmaceutical Asset Managements Market Trends
    Table 3. Pharmaceutical Asset Managements Market Drivers
    Table 4. Pharmaceutical Asset Managements Market Challenges
    Table 5. Pharmaceutical Asset Managements Market Restraints
    Table 6. Global Pharmaceutical Asset Managements Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pharmaceutical Asset Managements Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pharmaceutical Asset Managements Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pharmaceutical Asset Managements Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pharmaceutical Asset Managements Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pharmaceutical Asset Managements Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Pharmaceutical Asset Managements Revenue Share by Player, 2017-2022
    Table 13. Global Pharmaceutical Asset Managements Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Pharmaceutical Asset Managements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Asset Managements as of 2021)
    Table 15. Top Players of Pharmaceutical Asset Managements in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Pharmaceutical Asset Managements Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Pharmaceutical Asset Managements Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Pharmaceutical Asset Managements Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Pharmaceutical Asset Managements Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Pharmaceutical Asset Managements Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Pharmaceutical Asset Managements Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Pharmaceutical Asset Managements Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Pharmaceutical Asset Managements Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Pharmaceutical Asset Managements Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Pharmaceutical Asset Managements Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Pharmaceutical Asset Managements Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Pharmaceutical Asset Managements Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. McKesson Corporation Company Details
    Table 31. McKesson Corporation Business Overview
    Table 32. McKesson Corporation Pharmaceutical Asset Managements Product
    Table 33. McKesson Corporation Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million)
    Table 34. McKesson Corporation Recent Development
    Table 35. Cerner Corporation Company Details
    Table 36. Cerner Corporation Business Overview
    Table 37. Cerner Corporation Pharmaceutical Asset Managements Product
    Table 38. Cerner Corporation Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million)
    Table 39. Cerner Corporation Recent Development
    Table 40. Siemens Healthcare Company Details
    Table 41. Siemens Healthcare Business Overview
    Table 42. Siemens Healthcare Pharmaceutical Asset Managements Product
    Table 43. Siemens Healthcare Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million)
    Table 44. Siemens Healthcare Recent Development
    Table 45. GE Healthcare Company Details
    Table 46. GE Healthcare Business Overview
    Table 47. GE Healthcare Pharmaceutical Asset Managements Product
    Table 48. GE Healthcare Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million)
    Table 49. GE Healthcare Recent Development
    Table 50. Allscripts Company Details
    Table 51. Allscripts Business Overview
    Table 52. Allscripts Pharmaceutical Asset Managements Product
    Table 53. Allscripts Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million)
    Table 54. Allscripts Recent Development
    Table 55. Epic System Company Details
    Table 56. Epic System Business Overview
    Table 57. Epic System Pharmaceutical Asset Managements Product
    Table 58. Epic System Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million)
    Table 59. Epic System Recent Development
    Table 60. IBM Corporation Company Details
    Table 61. IBM Corporation Business Overview
    Table 62. IBM Corporation Pharmaceutical Asset Managements Product
    Table 63. IBM Corporation Revenue in Pharmaceutical Asset Managements Business (2017-2022) & (US$ Million)
    Table 64. IBM Corporation Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pharmaceutical Asset Managements Product Picture
    Figure 2. Global Pharmaceutical Asset Managements Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pharmaceutical Asset Managements Market Size 2017-2028 (US$ Million)
    Figure 4. United States Pharmaceutical Asset Managements Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Pharmaceutical Asset Managements Market Size 2017-2028 (US$ Million)
    Figure 6. United States Pharmaceutical Asset Managements Market Share in Global 2017-2028
    Figure 7. Pharmaceutical Asset Managements Report Years Considered
    Figure 8. Product Picture of Hardware (Pharma Asset)
    Figure 9. Product Picture of Software (Pharma Asset)
    Figure 10. Global Pharmaceutical Asset Managements Market Share by Type in 2022 & 2028
    Figure 11. Global Pharmaceutical Asset Managements Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Pharmaceutical Asset Managements Market Share by Type (2017-2028)
    Figure 13. United States Pharmaceutical Asset Managements Market Share by Type in 2022 & 2028
    Figure 14. United States Pharmaceutical Asset Managements Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Pharmaceutical Asset Managements Market Share by Type (2017-2028)
    Figure 16. Product Picture of Anti-Drug Counterfeiting
    Figure 17. Product Picture of Supply Chain Management
    Figure 18. Product Picture of Other
    Figure 19. Global Pharmaceutical Asset Managements Market Share by Application in 2022 & 2028
    Figure 20. Global Pharmaceutical Asset Managements Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Pharmaceutical Asset Managements Market Share by Application (2017-2028)
    Figure 22. United States Pharmaceutical Asset Managements Market Share by Application in 2022 & 2028
    Figure 23. United States Pharmaceutical Asset Managements Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Pharmaceutical Asset Managements Market Share by Application (2017-2028)
    Figure 25. North America Pharmaceutical Asset Managements Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Pharmaceutical Asset Managements Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Pharmaceutical Asset Managements Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Pharmaceutical Asset Managements Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Pharmaceutical Asset Managements Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Pharmaceutical Asset Managements Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. McKesson Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2017-2022)
    Figure 54. Cerner Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2017-2022)
    Figure 55. Siemens Healthcare Revenue Growth Rate in Pharmaceutical Asset Managements Business (2017-2022)
    Figure 56. GE Healthcare Revenue Growth Rate in Pharmaceutical Asset Managements Business (2017-2022)
    Figure 57. Allscripts Revenue Growth Rate in Pharmaceutical Asset Managements Business (2017-2022)
    Figure 58. Epic System Revenue Growth Rate in Pharmaceutical Asset Managements Business (2017-2022)
    Figure 59. IBM Corporation Revenue Growth Rate in Pharmaceutical Asset Managements Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
McKesson Corporation
Cerner Corporation
Siemens Healthcare
GE Healthcare
Allscripts
Epic System
IBM Corporation
Frequently Asked Questions
Pharmaceutical Asset Managements report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmaceutical Asset Managements report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmaceutical Asset Managements report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports